secwatch.observer — SEC 8-K summary
======================================

Issuer:     PALISADE BIO, INC. (PALI)
CIK:        0001357459
Form:       8-K
Filed at:   2024-04-05T23:59:59+00:00
Accession:  0001493152-24-013336
Event type: other
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Palisade Bio completes 1-for-15 reverse stock split to meet Nasdaq minimum bid price
--------------------------------------------------------------------------------

- 1-for-15 reverse split effective April 5, 2024; shares reduced from 12,771,015 to ~851,401.
- Split approved by shareholders on March 25, 2024; trading begins split-adjusted April 8 under PALI.
- Primary purpose: increase per-share price to regain compliance with Nasdaq's $1.00 minimum bid requirement.
- No fractional shares issued; cash paid in lieu of fractional interests.
- Conversion/exercise prices of preferred stock, warrants, and options proportionally adjusted by factor of 15.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1357459/000149315224013336/0001493152-24-013336-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1357459/000149315224013336/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-013336

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer